# Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

> **NCT03706261** · PHASE1 · COMPLETED · sponsor: **Adam Brickman** · enrollment: 145 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** 18F-MK-6240
- **DRUG:** 18F-Florbetaben

## Key facts

- **NCT ID:** NCT03706261
- **Lead sponsor:** Adam Brickman
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-22
- **Primary completion:** 2023-07-14
- **Final completion:** 2023-07-14
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2025-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03706261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03706261, "Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03706261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*